Jazz Pharmaceuticals to initiate study of JZP-458 to treat ALL
Jazz Pharmaceuticals is set to initiate a single-arm, pivotal Phase II/III study of JZP-458 as...
Deals this week: PeptiDream, Proteus Digital Health, Novartis
PeptiDream has entered an agreement with Shionogi for identifying and developing a series of blood-brain...
M&As this week: MabSpace Biosciences, Cambrex, Hetero Labs
MabSpace Biosciences has merged with HJB to create a fully-integrated biotherapeutics company named Transcenta Holding.